semaglutide nash phase 3 Drug Development: Seeing the Light at the End of the Tunnel? Novo Nordisk's semaglutide delivers in

The Wegovy pill, approved in December 2025, is the first oral GLP-1 medication formally indicated for chronic weight management in adults

But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people dont recognize known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days

Based on her earlier research on the syndrome, she says that semaglutide probably wont have an effect on patients who are at an ideal weight

If youre thinking about beginning your weight loss journey with Wegovy, you may find it beneficial to have an understanding of what to expect along the way